Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human NPY1R Antibodies:
anti-Rat (Rattus) NPY1R Antibodies:
anti-Mouse (Murine) NPY1R Antibodies:
Go to our pre-filtered search.
Bat Polyclonal NPY1R Primary Antibody for IHC (p) - ABIN270506
Matyal, Mahmood, Robich, Glazer, Khabbaz, Hess, Bianchi, Hagberg, Hu, Sellke: Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue. in European journal of pharmacology 2011
Human Monoclonal NPY1R Primary Antibody for ELISA, WB - ABIN562042
Igura, Haider, Ahmed, Sheriff, Ashraf: Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells. in Rejuvenation research 2011
NPY1R plays an inhibitory role in tumor growth and may be a promising therapeutic target for Hepatocellular carcinoma
expressed in to B (show TDO2 Antibodies) and T lymphocytes and mast cells in infantile hemangiomas
MAPK (show MAPK1 Antibodies) activation by NPY (show NPY Antibodies) Y1 receptors is an internalization-independent pathway and that this receptor can transactivate the IGFR receptor.
Report design of argininamide-type NPY1R antagonists.
NPY (show NPY Antibodies) and its Y receptor are possible mediators of both vasoconstriction and pulmonary vascular remodelling in pulmonary hypertension
Y1R expression in visceral adipose tissue might be an indicator of increased risk of metabolic syndrome.
The influence of beta-arrestin adaptors and endocytosis mechanisms on plasma membrane diffusion and particle brightness of GFP-tagged neuropeptide Y (NPY (show NPY Antibodies)) receptors, was investigated.
Npy1 receptor transgene overexpression is associated with modest anxiolytic-like effect on mice in the open field and elevated plus maze tests.
For the first time we report a significant association between nicotine dependence and DRD5 (show DRD5 Antibodies), NPY1R MAP3K4 (show MAP3K4 Antibodies) single nucleotide polymorphism.
neuropeptide Y1 and Y2 receptors were expressed in 33 percent of testicular tumors and Y1 on intratumoral blood vessels in 50 percent of testicular tumors
Lower mRNA levels of neuropeptide Y (show NPY Antibodies) receptor 1 (NPY1R) and NPY5R (show NPY5R Antibodies) but not NPY (show NPY Antibodies) or NPY2R (show NPY2R Antibodies) in the central nucleus of the amygdala predicted elevated anxious temperament.
Results suggest that rabbit and human Y1, Y2 and Y5 receptor (show NPY5R Antibodies) subtypes are well conserved, whereas Y4 receptors are less well conserved.
NPY (show NPY Antibodies) deficient mice had significantly impaired Hematopoietic stem/progenitor cell (HSPC (show PSMA7 Antibodies)) mobilization due to increased expression of HSPC (show PSMA7 Antibodies) maintenance factors by reduction of matrix metalloproteinase-9 (MMP-9 (show MMP9 Antibodies)) activity in bone marrow.
The vasoconstrictive mechanism has been identified as neuropeptide Y (show NPY Antibodies) acting on Y1 receptors.
findings suggest that reduced Y1R expression leads to a decrease in resting vagal modulation and heart rate variability, which, in turn, may determine a reduced cardiac autonomic responsiveness to acute stress challenges.
conditional inactivation of Y1 receptors specifically in Y5 receptor (show NPY5R Antibodies) containing neurons increases stress-related anxiety without affecting endocrine stress responses.
Npy1r(Y5R (show NPY5R Antibodies)-/-) mice show increased anxiety-related behavior but no changes in hypothalamus-pituitary-adrenocortical axis activity or in body weight growth, independently of gender and mouse strain used as foster mothers. Also, Npy1r(Y5R (show NPY5R Antibodies)-/-) mice of both genders display increased spatial reference memory in the Morris water maze test.
Study shows pronounced adaptive changes in the mouse hippocampus both with regard to NPY (show NPY Antibodies) synthesis and NPY (show NPY Antibodies) receptor synthesis and binding, which may contribute to regulating neuronal seizure susceptibility after kainate
an integrated neural circuit modulates growth hormone release relative to food intake; data provide essential information to address the differential roles of Y1 and Y2 receptors in regulating the release of GH under fed and fasting states
Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 (show BMP2 Antibodies) in C2C12 myoblasts
Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin (show INS Antibodies) resistance associated with diet-induced obesity.
Neuropeptide Y (NPY\; MIM 162640) is one of the most abundant neuropeptides in the mammalian nervous system and exhibits a diverse range of important physiologic activities, including effects on psychomotor activity, food intake, regulation of central endocrine secretion, and potent vasoactive effects on the cardiovascular system. Two major subtypes of NPY (Y1 and Y2) have been defined by pharmacologic criteria. NPY receptors, such as NPY1R, have been identified in a variety of tissues, including brain, spleen, small intestine, kidney, testis, placenta, and aortic smooth muscle (Herzog et al., 1992
neuropeptide Y receptor type 1
, Neuropepetide Y1 Receptor
, neuropeptide Y1 receptor
, neuropeptide Y Y1 receptor
, G-protein coupled receptor
, neuropeptide Y receptor Y1
, Y1 neuropeptide Y receptor
, Neuropeptide Y receptor type 1
, gastric Y1 receptor
, neuropeptide Y receptor type 1-like
, NPY-1 receptor
, neuropeptide Y receptor subtype
, neuropeptide Y receptor Y1, NPY/PYY receptor Y1